Search research articles
Contact Us
Filters
Showing results (71-80 of 74) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 74 results.
Nature
|
August 3, 2021
Publisher Correction: Global absence and targeting of protective immune states in severe COVID-19
Alexis J Combes, Tristan Courau, Nicholas F Kuhn, et al.
Biorxiv : the Preprint Server for Biology
|
March 24, 2021
Longitudinal single-cell epitope and RNA-sequencing reveals the immunological impact of type 1 interferon autoantibodies in critical COVID-19: Anti-IFN antibodies in critical COVID-19 correlate with poor ISG response and upregulation of LAIR1 surface protein in PBMCs
Monique G P van der Wijst, Sara E Vazquez, George C Hartoularos, et al.
Science Translational Medicine
|
August 25, 2021
Type I interferon autoantibodies are associated with systemic immune alterations in patients with COVID-19
Monique G P van der Wijst, Sara E Vazquez, George C Hartoularos, et al.
Iscience
|
October 9, 2023
A myeloid program associated with COVID-19 severity is decreased by therapeutic blockade of IL-6 signaling
Jason A Hackney, Haridha Shivram, Jason Vander Heiden, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 74) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 74 results.
Nature
|
August 3, 2021
Publisher Correction: Global absence and targeting of protective immune states in severe COVID-19
Alexis J Combes, Tristan Courau, Nicholas F Kuhn, et al.
Biorxiv : the Preprint Server for Biology
|
March 24, 2021
Longitudinal single-cell epitope and RNA-sequencing reveals the immunological impact of type 1 interferon autoantibodies in critical COVID-19: Anti-IFN antibodies in critical COVID-19 correlate with poor ISG response and upregulation of LAIR1 surface protein in PBMCs
Monique G P van der Wijst, Sara E Vazquez, George C Hartoularos, et al.
Science Translational Medicine
|
August 25, 2021
Type I interferon autoantibodies are associated with systemic immune alterations in patients with COVID-19
Monique G P van der Wijst, Sara E Vazquez, George C Hartoularos, et al.
Iscience
|
October 9, 2023
A myeloid program associated with COVID-19 severity is decreased by therapeutic blockade of IL-6 signaling
Jason A Hackney, Haridha Shivram, Jason Vander Heiden, et al.
Page
of 8